Oncology & Cancer
Douching: more harmful than helpful
(HealthDay)—Douching is the age-old practice of using a solution to attempt to clean the vagina, but there's only downsides to it.
Apr 2, 2019
0
3
Ovarian Cancer
Oncology & Cancer
New class of drugs could treat ovarian cancer
A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.
Mar 19, 2019
0
5
Oncology & Cancer
How to catch ovarian cancer earlier
Fewer than half of ovarian cancer patients survive until five years after diagnosis. According to the American Cancer Society, this is because only about one-fifth of ovarian cancer cases are detected early, when the chances ...
Mar 15, 2019
0
119
Oncology & Cancer
Targeting stem-like cells could prevent ovarian cancer recurrence
Ovarian cancer is not the most common form of cancer, but it's among the deadliest. That's because about 70 percent of cases recur. A new study by researchers at the University of Pittsburgh, UPMC Hillman Cancer Center, Magee-Womens ...
Mar 12, 2019
0
605
Oncology & Cancer
Mini tumors could help identify personalized treatments for people with rare cancers
UCLA scientists have developed a new method to quickly screen hundreds of drugs in order to identify treatments that can target specific tumors.
Feb 25, 2019
0
5
Oncology & Cancer
U.S. agencies probing Johnson & Johnson over asbestos in talc
(HealthDay)—Johnson & Johnson is being investigated by the U.S. Justice Department and the U.S. Securities and Exchange Commission over possible asbestos contamination of the company's baby powder and other talc-based products.
Feb 22, 2019
0
0
Oncology & Cancer
Breast cancer study confirms importance of multigenerational family data to assess risk
A team of researchers led by Columbia University Mailman School of Public Health Professor Mary Beth Terry, Ph.D., evaluated four commonly used breast cancer prediction models and found that family-history-based models perform ...
Feb 21, 2019
0
33
Oncology & Cancer
Artificial intelligence can predict survival of ovarian cancer patients
The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne, has been able to predict the prognosis of patients with ovarian cancer more accurately than current ...
Feb 15, 2019
0
332
Oncology & Cancer
New drug targets for BRCA-driven cancer uncovered
BRCA1 and BRCA2 ("BReast CAncer genes") are critical tumor suppressor genes—women carrying a mutation in one of these genes have up to an 80 percent risk of developing breast cancer and a 50 percent risk of developing ovarian ...
Jan 24, 2019
1
36
Oncology & Cancer
Anticancer immunity through tumor antigen identification and conversion to DNA vaccines
Wistar scientists and collaborators demonstrated the utility of an optimized synthetic DNA vaccine platform for rapidly inducing immunity against unique combinations of tumor neoantigens. These results reveal a direct pathway ...
Jan 24, 2019
1
1
